logo
Sign in

HAE Stock Price, Chart, Stats & News

Haemonetics Corporation
Save
3.31B
Market cap
14.66x
Current P/E
13.95x
Forward P/E

HAE chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
58.49%
Operating margin
19.21%
Pretax margin
17.23%
Net margin
13.31%
Effective tax rate
22.77%
ROA
7.04%
ROE
20.26%
D/E
1.34x
Interest coverage ratio
12.66x

HAE valuation

P/E
14.66x
P/S
1.92x
P/B
2.77x
P/CF
7.46x
P/FCF
8.21x
P/OCF
7.46x
PEG
2.36x
EV multiple
4.44x

About

Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains.

Similar securities

Based on sector and market capitalization

Report issue